[HTML][HTML] Ischemia/reperfusion

T Kalogeris, CP Baines, M Krenz… - Comprehensive …, 2016 - ncbi.nlm.nih.gov
Ischemic disorders, such as myocardial infarction, stroke, and peripheral vascular disease,
are the most common causes of debilitating disease and death in westernized cultures. The …

Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation

S Shukla, BL Tekwani - Frontiers in pharmacology, 2020 - frontiersin.org
Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue
of histones and non-histone proteins and regulate the process of transcription by binding to …

Cell death mechanisms in stroke and novel molecular and cellular treatment options

E Sekerdag, I Solaroglu… - Current …, 2018 - ingentaconnect.com
As a result of ischemia or hemorrhage, blood supply to neurons is disrupted which
subsequently promotes a cascade of pathophysiological responses resulting in cell loss …

Cell biology of ischemia/reperfusion injury

T Kalogeris, CP Baines, M Krenz, RJ Korthuis - International review of cell …, 2012 - Elsevier
Disorders characterized by ischemia/reperfusion (I/R), such as myocardial infarction, stroke,
and peripheral vascular disease, continue to be among the most frequent causes of …

The emerging field of epigenetics in neurodegeneration and neuroprotection

JY Hwang, KA Aromolaran, RS Zukin - Nature Reviews Neuroscience, 2017 - nature.com
Epigenetic mechanisms—including DNA methylation, histone post-translational
modifications and changes in nucleosome positioning—regulate gene expression, cellular …

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder

CT Chiu, Z Wang, JG Hunsberger, DM Chuang… - Pharmacological …, 2013 - Elsevier
The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar
disorder (BD), a severe mental illness arising from complex interactions between genes and …

Multiple roles of HDAC inhibition in neurodegenerative conditions

DM Chuang, Y Leng, Z Marinova, HJ Kim… - Trends in neurosciences, 2009 - cell.com
Histone deacetylases (HDACs) play a key role in homeostasis of protein acetylation in
histones and other proteins and in regulating fundamental cellular activities such as …

Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates

J Nair, VHS Kumar - Children, 2018 - mdpi.com
Neonatal hypoxic ischemic encephalopathy (HIE) presents a significant clinical burden with
its high mortality and morbidity rates globally. Therapeutic hypothermia (TH) is now standard …

Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?

B Fleiss, P Gressens - The Lancet Neurology, 2012 - thelancet.com
Cerebral palsy is caused by injury or developmental disturbances to the immature brain and
leads to substantial motor, cognitive, and learning deficits. In addition to developmental …

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

AG Kazantsev, LM Thompson - Nature reviews Drug discovery, 2008 - nature.com
Histone deacetylases (HDACs)—enzymes that affect the acetylation status of histones and
other important cellular proteins—have been recognized as potentially useful therapeutic …